Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-07-14
1983-11-22
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424DIG14, A61K 31185
Patent
active
044168977
ABSTRACT:
The use of 8-anilino-1-naphthalenesulfonate by injecting or introducing such drug directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drug are disclosed, such as by mixing such drug with jelly carriers, foam carriers, or paraffin oil.
REFERENCES:
Laporte et al. Biochemistry, 1980, p. 3814.
Hidaka et al.-Molecular Pharmacology, 15, pp. 49, 52, 1978.
Hidaka et al.-Molecular Pharmacology, 17, p. 66, 1979.
Hidaka et al.-Biochemical & Biophysical Research Comm., p. 694, 1979.
Kobyashi et al.-Biochemical & Biophysical Research Comm., p. 1037, 1979.
Schenkman Leonard
University of Georgia Research Foundation Inc.
LandOfFree
Use of 8-anilino-1-naphthalenesulfonate in the uterus to prevent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 8-anilino-1-naphthalenesulfonate in the uterus to prevent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 8-anilino-1-naphthalenesulfonate in the uterus to prevent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814834